Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot
WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $37.7 million in its fiscal second quarter.
On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of $1.79.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.91 per share.
The biotechnology company posted revenue of $17.8 million in the period, missing Street forecasts. Six analysts surveyed by Zacks expected $19.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA
